because the age-related increase in veb does not appear to increase cardiac mortality in older subjects without demonstrable heart disease , and given the significant likelihood of adverse effects from antiarrhythmic drugs in their age group , these drugs should be reserved for elderly patients with organic heart disease and frequent or complex veb .
C0018787
cardiac
C0018799
heart disease